- Home
- ENTX vs PRE Comparison
ENTX vs PRE Comparison
Compare ENTX & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- PRE
- Stock Information
- Founded
- ENTX 2010
- PRE 2014
- Country
- ENTX Israel
- PRE Hong Kong
- Employees
- ENTX N/A
- PRE N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- ENTX Health Care
- PRE Industrials
- Exchange
- ENTX Nasdaq
- PRE Nasdaq
- Market Cap
- ENTX 104.0M
- PRE 120.7M
- IPO Year
- ENTX 2018
- PRE N/A
- Fundamental
- Price
- ENTX $1.86
- PRE $8.06
- Analyst Decision
- ENTX Strong Buy
- PRE Buy
- Analyst Count
- ENTX 1
- PRE 1
- Target Price
- ENTX $10.00
- PRE $9.00
- AVG Volume (30 Days)
- ENTX 40.5K
- PRE 50.2K
- Earning Date
- ENTX 08-08-2025
- PRE 08-05-2025
- Dividend Yield
- ENTX N/A
- PRE N/A
- EPS Growth
- ENTX N/A
- PRE N/A
- EPS
- ENTX N/A
- PRE N/A
- Revenue
- ENTX $223,000.00
- PRE $41,520,000.00
- Revenue This Year
- ENTX N/A
- PRE $198.17
- Revenue Next Year
- ENTX N/A
- PRE $59.73
- P/E Ratio
- ENTX N/A
- PRE N/A
- Revenue Growth
- ENTX N/A
- PRE 78.72
- 52 Week Low
- ENTX $1.41
- PRE $3.10
- 52 Week High
- ENTX $2.79
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- ENTX 44.39
- PRE 49.76
- Support Level
- ENTX $1.91
- PRE $7.78
- Resistance Level
- ENTX $2.04
- PRE $8.80
- Average True Range (ATR)
- ENTX 0.10
- PRE 0.42
- MACD
- ENTX 0.00
- PRE -0.02
- Stochastic Oscillator
- ENTX 37.84
- PRE 36.32
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.